// App-Quantinova.ai

249 : MP‐AzeFlu improves quality of life of patients with allergic rhinitis: A real‐world study

Researchers

Presenter

  • Van Weissenbruch R

Principal Investigators

  • Klimek L

  • Glffy G

  • Emmeluth M

  • Koltun A

  • Kopietz F

  • Nguyen DT

  • Kuhl HC

  • Pohl W

  • Scadding G

  • Price D

  • Mullol J

Medical Centers

  • Wilhelmina Ziekenhuis Assen, Assen, Netherlands

  • Center of Rhinology and Allergology, Wiesbaden, Germany

  • Pulmonology Hospital, Törökbálint, Hungary

  • MEDA Pharma GmbH & Co. KG

  • Bad Homburg, Germany

  • Mylan, Inc, Canonsburg, United States

  • Karl Landsteiner Gesellschaft, Institut für Klinische und experimentelle Pneumologie, Vienna, Austria

  • Royal National Throat Nose and Ear Hospital, London, United Kingdom

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

  • Optimum Patient Care, Cambridge, United Kingdom,

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • Rhinology Unit & Smell Clinic, ENT Department, Hospital Clinic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain

Locations

  • Netherlands

  • Germany

  • Hungary

  • United States

  • Austria

  • United Kingdom

  • Singapore

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Allergic rhinitis

Biomarkers

  • N/A

Drug/Treatment

  • Nostril

Outcome

  • N/A

Study Design

  • Non Interventional

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved